Works matching IS 07248741 AND DT 2022 AND VI 39 AND IP 8
Results: 22
In-Vivo Tape Stripping Study with Caffeine for Comparisons on Body Sites, Age and Washing.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1935, doi. 10.1007/s11095-022-03311-0
- By:
- Publication type:
- Article
Lack of an Effect of Polysorbate 80 on Intestinal Drug Permeability in Humans.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1881, doi. 10.1007/s11095-022-03312-z
- By:
- Publication type:
- Article
Correction to: Liposomal Formulation for Oral Delivery of Cyclosporine A: Usefulness as a Semisolid-Dispersion System.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Applications of Model Informed Drug Development (MIDD) in Drug Development Lifecycle and Regulatory Review.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1663, doi. 10.1007/s11095-022-03327-6
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics – a Minireview.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1749, doi. 10.1007/s11095-022-03333-8
- By:
- Publication type:
- Article
Microneedle-Mediated Permeation Enhancement of Chlorhexidine Digluconate: Mechanistic Insights Through Imaging Mass Spectrometry.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1945, doi. 10.1007/s11095-022-03309-8
- By:
- Publication type:
- Article
Investigation of an Uncommon Artifact during Reducing Capillary Electrophoresis-Sodium Dodecyl Sulfate Analysis of a Monoclonal Antibody with Dynamic Light Scattering and Reversed Phase High-Performance Liquid Chromatography.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1959, doi. 10.1007/s11095-022-03303-0
- By:
- Publication type:
- Article
Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1823, doi. 10.1007/s11095-022-03301-2
- By:
- Publication type:
- Article
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1851, doi. 10.1007/s11095-022-03297-9
- By:
- Publication type:
- Article
Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1789, doi. 10.1007/s11095-022-03295-x
- By:
- Publication type:
- Article
Mechanistic Modeling of the Effect of Recombinant Human Hyaluronidase (rHuPH20) on Subcutaneous Delivery of Cetuximab in Rats.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1867, doi. 10.1007/s11095-022-03294-y
- By:
- Publication type:
- Article
Development of Physiology Based Pharmacokinetic Model to Predict the Drug Interactions of Voriconazole and Venetoclax.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1921, doi. 10.1007/s11095-022-03289-9
- By:
- Publication type:
- Article
Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1669, doi. 10.1007/s11095-022-03288-w
- By:
- Publication type:
- Article
Applications of Model-Based Meta-Analysis in Drug Development.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1761, doi. 10.1007/s11095-022-03201-5
- By:
- Publication type:
- Article
Improved Confidence in a Confirmatory Stage by Application of Item-Based Pharmacometrics Model: Illustration with a Phase III Active Comparator-Controlled Trial in COPD Patients.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1779, doi. 10.1007/s11095-022-03194-1
- By:
- Publication type:
- Article
The Use of Physiologically Based Pharmacokinetic Analyses—in Biopharmaceutics Applications -Regulatory and Industry Perspectives.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1681, doi. 10.1007/s11095-022-03280-4
- By:
- Publication type:
- Article
Applications, Challenges, and Outlook for PBPK Modeling and Simulation: A Regulatory, Industrial and Academic Perspective.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1701, doi. 10.1007/s11095-022-03274-2
- By:
- Publication type:
- Article
Population Pharmacokinetic Evaluation with External Validation of Tacrolimus in Chinese Primary Nephrotic Syndrome Patients.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1907, doi. 10.1007/s11095-022-03273-3
- By:
- Publication type:
- Article
Design and Development of a New Glucagon-Like Peptide-1 Receptor Agonist to Obtain High Oral Bioavailability.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1891, doi. 10.1007/s11095-022-03265-3
- By:
- Publication type:
- Article
Dose Finding in Oncology: What is Impeding Coming of Age?
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1817, doi. 10.1007/s11095-022-03263-5
- By:
- Publication type:
- Article
Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1733, doi. 10.1007/s11095-022-03250-w
- By:
- Publication type:
- Article
Role of Disease Progression Models in Drug Development.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 8, p. 1803, doi. 10.1007/s11095-022-03257-3
- By:
- Publication type:
- Article